---
uid: 20260215162102
tags: [#atomic #dt-clinic #hashimoto #vitD #selenium #deficiency #thyroid #autoimmune #micronutrients #phd #ir #t2d #metabolomics #syndemic #hpa #tsh]
parent-moc: [[PhD_IR_MOC_20260215_080]] | [[55-MOCs/Literature]]
aliases: [VitD_Selenium_Def_Hashimoto]
status: atomic
confidence: high
source: [[VitD_Def_Hashimoto_Prevalence_20260215_087]] | [[Protocol_HighDose_VitD_Hashimoto_20260215_111]]
---

# VitD_Selenium_Def_20260215_060

**Core Idea**: Synergistic VitD and selenium deficiencies exacerbate Hashimoto's by impairing deiodinase activity and VDR signaling, leading to T4-to-T3 conversion failure and Th1/Th17 skew.

**Context/Chain**: [[VitD_Def_Hashimoto_Prevalence_20260215_087]] | [[Hashimoto_Stress_Breach_20260215_059]] | [[FatSolubles_SafeHighDose_20260215_010]] | [[PhD_IR_MOC_20260215_080]].

**Sources/Data**: VitD<30ng/ml + Se<70ug/L in 78% Hashimoto (OR=3.2 for hypo); combo supp reduces TPO-Ab 40%.

**RON Ledger**: Input=micronut lit; Output=precision VitD/Se dosing protocol.
**Questions/Next**: Metabolomic signature of VitD/Se def in thyroiditis?